David Matly insider trades
Open-market stock purchases and sales by David Matly, President at Inhibrx Biosciences, Inc, from SEC Form 4 filings since Apr 1, 2025.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Apr 24, 2026 | INBX Inhibrx Biosciences, Inc | Bought (not open market) | — |
Companies traded
- INBX Inhibrx Biosciences, Inc: other filings, last Apr 24, 2026